Exousia Bio Ratios (2022-2025) | LMMY

Ratios May2022 Aug2022 Nov2022 Feb2023 May2023 Aug2023 Nov2023 Feb2024 May2024 Aug2024 Nov2024 Feb2025 May2025 Aug2025 Nov2025
Profitability
Gross Margin (Quarter) 100.00%100.00%-157.79%100.00%
EBT Margin (Quarter) -92.21%-124.39%-140.08%-104.29%
EBIT Margin (Quarter) -192.21%-224.39%289.04%-115.79%
EBITDA Margin (Quarter) -192.21%-224.39%289.04%-17.76%
Operating Margin (Quarter) -192.21%-224.39%289.04%-115.79%
Net Margin (Quarter) -92.21%-124.39%-140.08%-104.29%
FCF Margin (Quarter) -43.97%-36.52%-37.71%-64.45%
Efficiency
Assets Average (Quarter) 0.04M0.03M0.03M0.03M0.03M0.03M0.03M
Equity Average (Quarter) -0.01M-0.02M-0.02M-0.03M-0.04M-0.04M-0.05M-0.05M-0.06M-0.02M10.88M
Invested Capital (Quarter) -437.00-0.01M-0.02M-0.03M-0.03M-0.04M-0.04M-0.05M-0.05M-0.06M0.02M-0.04M21.79M
Asset Utilization Ratio (Quarter) 0.140.290.420.550.43
Leverage & Solvency
Interest Coverage Ratio (Quarter) -3.07
Equity Ratio (Quarter) -0.01-0.73-0.79-1.54-1.68-1.84-2.00-2.101.000.99
Times Interest Earned (Quarter) -3.07
Valuation
Enterprise Value (Quarter) -0.01M-0.00M-0.00M-0.01M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Return Ratios
Return on Sales (Quarter) -0.01%-0.01%-0.01%-0.01%0.06%0.18%0.36%
Return on Capital Employed (Quarter) -36.03%-49.20%-61.80%-77.20%-152.77%-91.55%
Return on Assets (Quarter) -0.02%-0.02%-0.02%-0.02%-0.01%-0.01%0.03%
Return on Equity (Quarter) 0.01%0.02%0.02%0.01%0.01%0.00%0.00%-0.04%0.00%